Medicare Enrolled
Dr. Poongothai Sundaram, MD
Medical Oncology · Columbus, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sundaram from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sundaram?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sundaram
Dr. Poongothai Sundaram is a medical oncology specialist in Columbus, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sundaram performed 7,433 Medicare services across 1,121 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sundaram received a total of $14,321 from 65 pharmaceutical and/or device companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sundaram is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in OH
$14,321 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,433
Medicare services
Top 18% in OH for medical oncology
1,121
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~372 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,682 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
846 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
677 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 420 | $1 | $41 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
315 | $90 | $390 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
202 | $10 | $67 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
150 | $8 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
145 | $59 | $277 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
136 | $94 | $421 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
101 | $1 | $6 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
91 | $21 | $103 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
82 | $76 | $210 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
74 | $11 | $66 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
53 | $1 | $4 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
48 | $44 | $205 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
45 | $4 | $12 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
41 | $43 | $372 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
38 | $131 | $740 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
33 | $5 | $16 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $136 | $550 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
29 | $47 | $208 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
27 | $27 | $121 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
27 | $61 | $214 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $104 | $509 |
| Whole body bone and joint nuclear medicine scan A nuclear medicine imaging test that uses a radioactive tracer to create pictures of the entire skeleton and joints. This scan helps evaluate bone health and detect abnormalities throughout the body. |
21 | $156 | $749 |
| Technetium Tc-99m medronate diagnostic injection An injection of Technetium Tc-99m medronate used for diagnostic imaging studies. The dose administered is up to 30 millicuries per study. |
21 | $18 | $85 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
19 | $766 | $4,464 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $100 | $406 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
13 | $26 | $86 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $134 | $595 |
| New patient office visit, complex (60-74 min) | 11 | $159 | $673 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.1% high complexity
74.6% medium
21.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,321
Total received (2018-2024)
Avg $2,046/year across 7 years
Top 18% in OH for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
258
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,841 (33.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,336 (30.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,043 (28.2%)
Other
Charitable contributions, space rental, and other categories
$1,102 (7.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,346
2023
$3,750
2022
$580
2021
$2,444
2020
$1,354
2019
$2,211
2018
$636
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$1,258
Novartis Pharmaceuticals Corporation
$1,102
Adaptive Biotechnologies Corporation
$149
Daiichi Sankyo Inc.
$77
Eisai Inc.
$68
Merck Sharp & Dohme LLC
$60
SpringWorks Therapeutics, Inc.
$56
Astellas Pharma US Inc
$55
Takeda Pharmaceuticals U.S.A., Inc.
$55
ABBVIE INC.
$45
Amneal Pharmaceuticals LLC
$36
Karyopharm Therapeutics Inc.
$33
Gilead Sciences, Inc.
$32
Janssen Biotech, Inc.
$31
BeiGene USA, Inc.
$29
GlaxoSmithKline, LLC.
$27
ARRAY BIOPHARMA INC
$25
Incyte Corporation
$24
Regeneron Healthcare Solutions, Inc.
$22
Lilly USA, LLC
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
SOBI, INC
$19
TAIHO ONCOLOGY, INC.
$18
SERVIER PHARMACEUTICALS LLC
$18
Celgene Corporation
$17
Genentech USA, Inc.
$16
EMD Serono, Inc.
$16
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 75.0% of 2024 payments
All-time payments by company (2018-2024) ›
Karyopharm Therapeutics Inc.
$2,139
Seattle Genetics, Inc.
$1,646
PFIZER INC.
$1,380
Seagen Inc.
$1,278
Novartis Pharmaceuticals Corporation
$1,250
Daiichi Sankyo Inc.
$1,077
Rigel Pharmaceuticals, Inc.
$1,040
Takeda Pharmaceuticals U.S.A., Inc.
$553
Eisai Inc.
$361
Exelixis Inc.
$286
Janssen Biotech, Inc.
$251
Heron Therapeutics, Inc.
$239
Celgene Corporation
$194
Gilead Sciences, Inc.
$184
GlaxoSmithKline, LLC.
$162
Merck Sharp & Dohme LLC
$157
Adaptive Biotechnologies Corporation
$149
GENZYME CORPORATION
$130
EISAI INC.
$116
Amgen Inc.
$101
EMD Serono, Inc.
$91
Ipsen Biopharmaceuticals, Inc
$84
Agios Pharmaceuticals, Inc.
$81
Taiho Oncology, Inc.
$69
Merck Sharp & Dohme Corporation
$65
Incyte Corporation
$63
AstraZeneca Pharmaceuticals LP
$59
BeiGene USA, Inc.
$57
SpringWorks Therapeutics, Inc.
$56
Astellas Pharma US Inc
$55
CTI BioPharma Corp.
$55
Amneal Pharmaceuticals LLC
$54
Dendreon Pharmaceuticals LLC
$53
Genentech USA, Inc.
$48
E.R. Squibb & Sons, L.L.C.
$45
ABBVIE INC.
$45
ARRAY BIOPHARMA INC
$44
ADC Therapeutics America, Inc.
$42
SERVIER PHARMACEUTICALS LLC
$40
Lilly USA, LLC
$38
AbbVie, Inc.
$36
AMAG Pharmaceuticals, Inc.
$34
Bayer HealthCare Pharmaceuticals Inc.
$31
Spectrum Pharmaceuticals Inc.
$29
Foundation Medicine, Inc.
$27
Dova Pharmaceuticals
$24
Regeneron Healthcare Solutions, Inc.
$22
Aveo Pharmaceuticals, Inc.
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Stemline Therapeutics Inc.
$20
Innate Pharma, Inc
$19
SOBI, INC
$19
TAIHO ONCOLOGY, INC.
$18
Genmab U.S., Inc.
$16
EUSA Pharma (US) LLC
$16
TOLMAR Pharmaceuticals, Inc.
$15
ImmunoGen, Inc.
$15
Secura Bio, Inc.
$15
Kyowa Kirin, Inc.
$14
Sumitomo Pharma America, Inc.
$14
Helsinn Therapeutics (U.S.), Inc.
$13
TESARO, Inc.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Lexicon Pharmaceuticals, Inc.
$11
Clovis Oncology, Inc.
$9
Top 3 companies account for 36.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · AVASTIN · Abraxane · BLENREP · BRUKINSA · Bavencio · CINVANTI · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELITEK · ENHERTU · ERLEADA · Elahere · Enhertu · Epkinly · FARESTON · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · JAKAFI · JAYPIRCA · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · MONJUVI · NINLARO · Neulasta · OGSIVEO · OJJAARA · OPDIVO · ORGOVYX · Odomzo · Orserdu · PADCEV · PLUVICTO · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SUSTOL · Stivarga · Sylvant · TABRECTA · TAGRISSO · TECVAYLI · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · VELCADE · Venclexta · Vonjo · XALKORI · XGEVA · XPOVIO · Xermelo · Xofigo · Xtandi · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (34%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
70
Per 100K population
5.3
County median income
$73,795
Nearest hospital
RIVER VISTA HEALTH AND WELLNESS LLC
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sundaram is a mixed practice specialist, with above-average Medicare volume (top 18% in OH), with mixed engagement industry engagement in the top 18% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sundaram experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Sundaram performed 3,682 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sundaram receive payments from pharmaceutical companies?
Yes. Dr. Sundaram received a total of $14,321 from 65 companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sundaram's costs compare to other medical oncologists in Columbus?
Dr. Sundaram's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sundaram) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Columbus
Browse medical oncologists in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in OH
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in OH
Which OH medical oncologists receive the most from drug and device companies.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology